Clinical Trials Directory

Trials / Completed

CompletedNCT06158984

Managing Dry Eye in Patients Using Glaucoma Drops

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
He Eye Hospital · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

A single center randomized controlled trial on managing dry eye signs and symptoms in patients using anti-glaucoma eye drops.

Detailed description

To compare the safety and efficacy of IPL therapy on drug-induced dry eye caused by long-term use of anti glaucoma drugs;

Conditions

Interventions

TypeNameDescription
DEVICEIPLIntense pulse light (IPL) therapy is used for the treatment of drug-related dry eye in glaucoma patients.

Timeline

Start date
2023-10-03
Primary completion
2023-12-01
Completion
2023-12-02
First posted
2023-12-06
Last updated
2023-12-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06158984. Inclusion in this directory is not an endorsement.

Managing Dry Eye in Patients Using Glaucoma Drops (NCT06158984) · Clinical Trials Directory